secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001558370-23-014214
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q2 2023 net loss $3.5M, revenue $58.9M; plans 1-2 more hospitals in 2023
--------------------------------------------------------------------------------

- Net revenue $58.9M in Q2 2023, essentially flat vs $58.0M in Q2 2022.
- Net loss attributable to Nutex Health $3.5M vs $19.3M loss in Q2 2022; Adjusted EBITDA $4.0M.
- Cash $32.8M; $100M Lincoln Park investment facility unused.
- Opened 4 micro-hospitals in 2023; expects 1-2 more in 2023 and 14 by end of 2025.
- Closed 3 unprofitable facilities (Texas); paid back $3.75M to Yorkville; $7.7M outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023014214/0001558370-23-014214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023014214/nutx-20230809x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-014214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer